ProfileGDS4718 / 225140_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 82% 77% 64% 81% 76% 69% 73% 74% 83% 77% 84% 75% 74% 72% 69% 79% 77% 72% 58% 43% 76% 77% 80% 82% 80% 74% 79% 61% 84% 64% 74% 64% 82% 87% 80% 66% 69% 55% 84% 63% 81% 63% 60% 73% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.1510982
GSM549102patient 115, normal, homogenized [OPG study]7.4207177
GSM549104patient 119, normal, homogenized [OPG study]6.4543164
GSM549108patient 138, normal, homogenized [OPG study]7.9137781
GSM549119patient 077, normal, homogenized [OPG study]7.3806676
GSM549133patient 032, cancer, homogenized [OPG study]6.8163769
GSM549139patient 042, cancer, homogenized [OPG study]7.1673473
GSM549099patient 107, normal, homogenized [OPG study]7.1257674
GSM549109patient 139, normal, homogenized [OPG study]8.1043983
GSM549110patient 046, normal, homogenized [OPG study]7.5096877
GSM549114patient 063, normal, homogenized [OPG study]8.3724784
GSM549122patient 082, normal, homogenized [OPG study]7.3522275
GSM549134patient 033, cancer, homogenized [OPG study]7.2253474
GSM549136patient 036, cancer, homogenized [OPG study]7.1469572
GSM549140patient 044, cancer, homogenized [OPG study]6.7917369
GSM549111patient 047, normal, homogenized [OPG study]7.7369679
GSM549113patient 057, normal, homogenized [OPG study]7.6395477
GSM549132patient 031, cancer, homogenized [OPG study]7.1007872
GSM549137patient 038, cancer, homogenized [OPG study]6.022658
GSM549142patient 047, cancer, homogenized [OPG study]5.2463343
GSM549100patient 110, normal, homogenized [OPG study]7.3789976
GSM549107patient 135, normal, homogenized [OPG study]7.5213277
GSM549115patient 068, normal, homogenized [OPG study]7.9488180
GSM549116patient 072, normal, homogenized [OPG study]8.1355882
GSM549120patient 078, normal, homogenized [OPG study]7.8084180
GSM549131patient 030, cancer, homogenized [OPG study]7.3076174
GSM549118patient 074, normal, homogenized [OPG study]7.7087179
GSM549129patient 027, cancer, homogenized [OPG study]6.2021761
GSM549123patient 088, normal, homogenized [OPG study]8.3065284
GSM549124patient 006, cancer, homogenized [OPG study]6.4194664
GSM549126patient 015, cancer, homogenized [OPG study]7.2527474
GSM549128patient 025, cancer, homogenized [OPG study]6.4519464
GSM549103patient 117, normal, homogenized [OPG study]8.0006182
GSM549117patient 073, normal, homogenized [OPG study]8.9342887
GSM549138patient 041, cancer, homogenized [OPG study]7.9102380
GSM549141patient 045, cancer, homogenized [OPG study]6.586566
GSM549130patient 028, cancer, homogenized [OPG study]6.7739769
GSM549101patient 111, normal, homogenized [OPG study]5.8631355
GSM549105patient 128, normal, homogenized [OPG study]8.2644584
GSM549106patient 134, normal, homogenized [OPG study]6.3661263
GSM549112patient 048, normal, homogenized [OPG study]8.0009481
GSM549125patient 011, cancer, homogenized [OPG study]6.3377763
GSM549127patient 024, cancer, homogenized [OPG study]6.2031660
GSM549135patient 035, cancer, homogenized [OPG study]7.2031973